BIOMAT Database Logo BIOMAT Database Logo

Bioavailability of nifedipine from different oral dosage forms in healthy volunteers. 1989

S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Institute of Medicine and Pharmacy, Department of Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romai.

The absolute and relative bioavailability of nifedipine (1) from different formulations administered as single oral doses in healthy volunteers was determined. Serum concentrations of 1 were measured by GC. The absolute bioavailability of 1 was 53% because of presystemic metabolism. The bioavailability of Adalat (Bayer) tablets, Nifedipina (Terapia) and Corinfar (VEB Arzneimittelwerk Dresden) sugar-coated tablets was 93%, 92% and 86% (respectively) as compared with Adalat capsules. The AUC were not significantly different. The Cmax and tmax values were different, indicating that the absorption of 1 showed differences in first-order rate constants of dissolution in the above mentioned order. Despite the differences among the formulations studied, each preparation may have its merits. In a multiple dose regimen of 20 mg 1 (Nifedipina, Terapia) t.i.d., minimal therapeutic drug levels were achieved and maintained during steady state, from the 1st d of treatment.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
[Comparison of the bioavailability of 2 different equal-dosage oral pharmaceutic forms of nimesulide in healthy volunteers].
August 1986, La Clinica terapeutica,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Relative bioavailability of carbocysteine from three dosage forms, investigated in healthy volunteers.
January 1988, Biopharmaceutics & drug disposition,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
January 1989, Archivos de investigacion medica,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
[Comparative bioavailability of 3 oral forms of metapramine in healthy volunteers].
January 1984, Therapie,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Bioavailability of phenobarbital from different pharmaceutical dosage forms.
January 1977, Pharmaceutica acta Helvetiae,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
January 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Bioavailability of valsartan oral dosage forms.
March 2014, Clinical pharmacology in drug development,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
October 1991, International journal of clinical pharmacology, therapy, and toxicology,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
Bioavailability from pharmaceutical dosage forms.
December 1974, The Analyst,
S E Leucuţa, and L Vida-Simiti, and M G Căprioară, and E Făgărăşan, and N Olinic, and M Manasia, and R Vlaicu
[Bioavailability and pharmacokinetics of a new nifedipine preparation in healthy volunteers].
May 1989, Arzneimittel-Forschung,
Copied contents to your clipboard!